33
DAFTAR PUSTAKA
Akinbami, L.J., Moorman, J.E., Bailey, C., Zahran, H.S., King, M., Johnson, C.A., Liu, X., 2012. Trends in Asthma Prevalence, Health Care Use, and Mortality in the United States, 2001-2010. Natlional Center Health Statatistics.
Amirav, I., Amitai, Y., Avital, A., Godfrey, S., 1998. Enhancement of Theophylline Clearance by Intravenous Albuterol. Chest 94, 444–445.
Ansari, J.A., 2010. Drug interaction and pharmacist. Journal of Young Pharmacists 2, 326–331.
Aronson, J.K., 2004. Classifying drug interactions. British Journal of Clinical Pharmacology 58, 343–344.
Barclay, J., Whiting, B., Meredith, P., Addis, G., 1981. Theophylline-salbutamol interaction: bronchodilator response to salbutamol at maximally effective plasma theophylline concentrations. British Journal of Clinical Pharmacology 11, 203–208.
Baxter, K. (Ed.), 2008. Stockley’s Drug Interactions. Pharmaceutical Press, London, p. 1099.
Becker, M.L., Kallewaard, M., Caspers, P.W.J., Schalekamp, T., Stricker, B.H.C., 2005. Potential Determinants of Drug-Drug Interaction Associated Dispensing in Community Pharmacies. Drug Safety 28, 371–378.
Boehning, W., 1990. Effect of cimetidine and ranitidine on plasma theophylline in patients with chronic obstructive airways disease treated with theophylline and corticosteroids. European Journal of Clinical Pharmacology 38, 43–5.
Burnakis, T.G., Mioduch, H.J., 1984. Combined therapy with captopril and potassium supplementation. A potential for hyperkalemia. Archives of Internal Medicine 144, 2371–2.
Chan, T.Y., Critchley, J.A., 1992. Life-threatening hyperkalaemia in an elderly patient receiving captopril, furosemide (frusemide) and potassium supplements. Drug Safety 7, 159–61.
Chow, O.K.W., Fung, K.P., 1989. Slow-Release Terbutaline and Theophylline for the Long-Term Therapy of Children With Asthma: A Latin Square and Factorial Study of Drug Effects and Interactions. Pediatrics 84, 119–125.
Departemen Kesehatan RI, 2007. Pharmaceutical Care Untuk Penyakit Asma. Departemen Kesehatan RI, Jakarta.
34
Edisworo, M.W., 2009. Hubungan Tingkat Pengetahuan Umum Asma dengan Tingkat Kontrol Asma di Poliklinik Asma Rumah Sakit Persahabatan Jakarta. Skripsi. Fakultas Kedokteran Universitas Indonsesia.
Farrokhnia, F., Arbabi, S., 2008. Effects of oral methylprednisolone and inhaled salbutamol in the decrease of wheezing in patients with asthma after tracheal intubation. DARU Journal of Pharmaceutical Science 16, 164–168.
Fergusson, R.J., Scott, C.M., Rafferty, P., Gaddie, J., 1987. Effect of prednisolone on theophylline pharmacokinetics in patients with chronic airflow obstruction. Thorax 42, 195–198.
Fost, D.A., Leung, D.Y.. ., Martin, R.J., Brown, E.E., Szefler, S.J., Spahn, J.D., 1999. Inhibition of methylprednisolone elimination in the presence of clarithromycin therapy. Journal of Allergy and Clinical Immunology 103, 1031–1035.
Gillissen, A., 2004. Managing asthma in the real world. International Journal of Clinical Practice 58, 592–603.
GINA, 2011. Pocket Guide for Asthma Management. Global Initiative For Asthma.
Hart, S.P., 2000. Should aminophylline be abandoned in the treatment of acute asthma in adults?. Quarterly Journal of Medicine 93, 761–5.
Hasan, S.S., Lim, K.N., Anwar, M., Sathvik, B.S., Ahmadi, K., Yuan, A.W.L.,
Kamarunnesa, M.A., 2012. Impact of pharmacists’ intervention on
identification and management of drug-drug interactions in an intensive care setting. Singapore Medical Journal 53, 526–31.
Hashem, G., 2005. Drug – Drug Interactions, Medicine. Cairo.
Jonas, D.E., Wines, R.C.M., 2011. Drug Class Review Controller Medications for Asthma. Drug Class Reviews, 1–369.
Juurlink, D.N., Mamdani, M., Kopp, A., Laupacis, A., Redelmeier, D.A., 2003. Drug-drug interactions among elderly patients hospitalized for drug toxicity. The Journal of the American Medical Association 289, 1652–1658.
Khaliq, Y., Zhanel, G.G., 2003. Fluoroquinolone-associated tendinopathy: a critical review of the literature. Clinical Infectious Diseases 36, 1404–10.
Kigen, G., Kimaiyo, S., Owen, A., Edwards, G., Back, D., Gibbons, S., Sang, E., Khoo, S., 2008. Prevalence of Drug Interactions Between Antiretroviral and Co-administered Drugs in Kenya Developed countries. Journal of Clinical Pharmacy Therapeutics.
35
Leynaert, B., Sunyer, J., Garcia-Esteban, R., Svanes, C., Jarvis, D., Cerveri, I., Dratva, J., Gislason, T., Heinrich, J., Janson, C., Kuenzli, N., de Marco, R., Omenaas, E., Raherison, C., Gómez Real, F., Wjst, M., Zemp, E., Zureik, M., Burney, P.G.J., Anto, J.M., Neukirch, F., 2012. Gender differences in prevalence, diagnosis and incidence of allergic and non-allergic asthma: a population-based cohort. Thorax 67, 625–31.
Littenberg, B., 1988. Aminophylline treatment in severe, acute asthma: A meta-analysis. The Journal of American Medical Association 259, 1678–1684.
Masoli, M., Fabian, D., Holt, S., Beasley, R., 2004. Developed for the Global Initiative for Asthma. Global Initiative for Asthma 1–122.
NAEPP, 2007. Guidelines for the Diagnosis and Management of Asthma. Journal of Allergy and Clinical Immunology 120, 28–29.
Nakajima, M., Suzuki, T., Sasaki, T., Yokoi, T., Hosoyamada, A., Yamamoto, T., Kuroiwa, Y., 1999. Effects of chronic administration of glucocorticoid on midazolam pharmacokinetics in humans. Therapeutic Drug Monitoring 21, 507–13.
National Institute of Health, 2011. Asthma Care Quick Reference: Diagnosing and Managing Asthma. National Institute of Health US Department of Health and Human Service.
Nelson, S.D., 2008. Drug Interactions. In: Rodrigues, D.A. (Ed.), Drug-Drug Interactions. Drug-Drug and The Pharmaceutical Sciences, New Jersey, p. 690.
Nishimuta, T., Kondo, N., Hamasaki, Y., Morikawa, A., Nishima, S., 2011. Japanese guideline for childhood asthma. Allergology International 60, 147– 169.
Pearce, N., Strachan, D., 2011. The Global Asthma Report 2011. Paris, France: The International Union Against Tuberculosis and Lung Disease. The International Study of Asthma and Allergies in Childhood, 76.
Rengganis, I., 2008. Diagnosis dan Tatalaksana Asma Bronkial. Majalah Kedokteran Indonesia, 58.
Rivianti, C., 2010. Tinjauan Interaksi Obat Pada Pasien Asma di INstalasi Rawat Inap Rumah Sakit Roemani Muhammadiyah Semarang Periode Maret 2008-Maret 2010. Skripsi. Fakultas Farmasi Universitas Muhammadiyah Surakarta.
36
Snyder, B.D., Polasek, T.M., Doogue, M.P., 2012. Drug interactions: principles and practice. Australian Presciber 35, 85–88.
Spivey, J.M., Laughlin, P.H., Goss, T.F., Nix, D.E., 2016. Theophylline toxicity secondary to ciprofloxacin administration. Annals of Emergency Medicine 20, 1131–1134.
Subbarao, P., Mandhane, P.J., Sears, M.R., 2009. Asthma: epidemiology, etiology and risk factors. Canadian Medical Association Journal 181, E181–190.
Sundaru, H., 2001. Buku Ajar Ilmu Penyakit Dalam, 3th ed. Balai Penerbit Fakultas Kedokteran Univeritas Indonesia, Jakarta.
Svedmyr, K., Lofdahl, C.-G., Svedmyr, N., 1984. Nifedipine - a Calcium Channel Blocker - in Asthmatic Patients Interaction with Terbutaline. Allergy 39, 17– 22.
Takarabe, M., Shigemizu, D., Goto, S., Kotera, M., Kanehisa, M., 2010. Characterization and Classification of Adverse Drug. Journal of Genome Inform, 167–175.
Tatro, D.S., 2012. Drug Interaction Facts 2012: The Authority on Drug Interactions. Wolters Kluwer Health, California.
Taylor, D.R., 2000. Interactions between corticosteroids and beta agonists. Thorax 55, 595–602.
Villikka, K., Varis, T., Backman, J.T., Neuvonen, P.J., Kivistö, K.T., 2001. Effect of methylprednisolone on CYP3A4-mediated drug metabolism in vivo. European Journal of Clinical Pharmacology 57, 457–60.
WHO, 2002. Prevention of Allergy and Allergic Asthma. Management of Noncommunicable Diseases Departement, 8–9.
